Related Experiment Videos
A somatic cell mutant with a kinetically altered 3-hydroxy-3-methylglutaryl coenzyme A reductase
FEBS Letters
|July 8, 1985
Summary
Researchers isolated a somatic cell mutant resistant to mevinolin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. This resistance, linked to a lower HMG-CoA binding affinity, provides a genetic marker for HMG-CoA reductase.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Mevinolin is a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase.
- Understanding HMG-CoA reductase function is crucial for cellular metabolism and drug development.
Purpose of the Study:
- To isolate and characterize somatic cell mutants resistant to mevinolin.
- To identify the genetic basis of mevinolin resistance.
- To establish mevinolin resistance as a genetic marker for HMG-CoA reductase.
Main Methods:
- Isolation of somatic cell mutants exhibiting resistance to mevinolin.
- Phenotypic analysis of mevinolin-resistant mutants.
- Biochemical assays to determine enzyme kinetics, specifically the Michaelis constant (KM) for HMG-CoA.
Main Results:
- A dominant somatic cell mutant resistant to mevinolin was successfully isolated.
- The resistance phenotype is associated with a 6-7 fold decrease in the KM for HMG-CoA.
- This indicates an altered affinity of the HMG-CoA reductase enzyme for its substrate.
Conclusions:
- Mevinolin resistance serves as a valuable dominant genetic marker.
- This marker can be used to study the structural gene encoding HMG-CoA reductase.
- The findings facilitate genetic analysis of HMG-CoA reductase and related metabolic pathways.